Literature DB >> 22235403

Granulosa cell tumors of the ovary and inhibin B.

N V Lyubimova1, A M Beyshembaev, D N Kushlinskiy, K I Zordania, L V Adamyan.   

Abstract

We present the results of immunoenzyme detection of inhibin B in blood serum of patients with adult-type granulosa cell tumors of the ovary. Blood concentration of inhibin B at the end of menstrual cycle in patients with tumor relapse was significantly higher than in patients during remission and in virtually healthy women. The increase in inhibin B concentration preceded clinical manifestation of the disease relapse by 2-13 months, which demonstrates high diagnostic sensitivity of this marker and suggests that it can be recommended for the use in diagnostics and monitoring of granulosa cell tumors of the ovaries.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22235403     DOI: 10.1007/s10517-011-1209-z

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study.

Authors:  Elizabeth R Burton; Mark Brady; Howard D Homesley; Peter G Rose; Toshiaki Nakamura; Joshua P Kesterson; Jacob Rotmensch; J Tate Thigpen; Linda Van Le
Journal:  Gynecol Oncol       Date:  2015-11-23       Impact factor: 5.482

2.  Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology Group.

Authors:  Jubilee Brown; William E Brady; Julian Schink; Linda Van Le; Mario Leitao; S Diane Yamada; Koen de Geest; David M Gershenson
Journal:  Cancer       Date:  2013-10-24       Impact factor: 6.860

Review 3.  Primary retroperitoneal extraovarian granulosa cell tumor.

Authors:  Pragya Sharma; Vikram Singh; Niharika Mishra; Manoj Gopinath; Prashant Gupta
Journal:  Autops Case Rep       Date:  2022-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.